The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Raises Intertek; UBS Cuts Segro

Tue, 19th Nov 2019 09:32

(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and late Monday:

----------

FTSE 100

----------

JEFFERIES RAISES INTERTEK TO 'BUY' ('HOLD') - TARGET 6100 (6300) PENCE

----------

HSBC CUTS PRUDENTIAL PRICE TARGET TO 1800 (1835) PENCE - 'BUY'

----------

UBS CUTS SEGRO PLC TO 'NEUTRAL' ('BUY') - TARGET 850 (820) PENCE

----------

RBC CUTS BRITISH LAND PRICE TARGET TO 550 (600) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS LAND SECURITIES PRICE TARGET TO 1075 (1100) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

RBC RAISES WORKSPACE GROUP PRICE TARGET TO 1200 (1050) PENCE - 'SECTOR PERFORM'

----------

CREDIT SUISSE RAISES QINETIQ PRICE TARGET TO 350 (325) PENCE - 'NEUTRAL'

----------

UBS RAISES QINETIQ PRICE TARGET TO 260 (240) PENCE - 'SELL'

----------

RBC RAISES WH SMITH PRICE TARGET TO 2600 (2400) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS DIPLOMA TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 1730 (1760) PENCE

----------

BARCLAYS RAISES DIPLOMA PLC PRICE TARGET TO 1500 (1420) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES CAPITAL & COUNTIES TARGET TO 230 (215) PENCE - 'UNDERWEIGHT'

----------

CITIGROUP CUTS B&M EUROPEAN VALUE RETAIL TO 'NEUTRAL' ('BUY') - TARGET 405 (410) PENCE

----------

DEUTSCHE BANK CUTS ASTON MARTIN PRICE TARGET TO 560 (600) PENCE - 'HOLD'

----------

CREDIT SUISSE RAISES EASYJET PRICE TARGET TO 1431 (1206) PENCE - 'OUTPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

RBC RAISES CONSORT MEDICAL PRICE TARGET TO 1200 (1060) PENCE - 'OUTPERFORM'

----------

BARCLAYS CUTS IQE PRICE TARGET TO 73 (80) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES KINGSPAN TARGET TO 4500 (4100) PENCE - 'EQUAL WEIGHT'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
9 Feb 2015 06:15

UK Dividends Calendar - Week Ahead

Read more
6 Feb 2015 16:01

UK Dividends Calendar - Week Ahead

Read more
4 Feb 2015 14:35

Sector movers: GSK leads defensive pharma stocks higher

A massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high. Sales, profits and earnings slumped during the fourth quarter of

Read more
4 Feb 2015 08:23

Consort Medical Signs Multi-Year Supply Agreement

Read more
29 Jan 2015 10:53

Consort Medical Invests Further GBP2.2 Million In Atlas Genetics

Read more
15 Jan 2015 06:21

UK Dividends Calendar - Week Ahead

Read more
14 Jan 2015 16:04

UK Dividends Calendar - Week Ahead

Read more
14 Jan 2015 06:15

UK Dividends Calendar - Week Ahead

Read more
13 Jan 2015 16:01

UK Dividends Calendar - Week Ahead

Read more
13 Jan 2015 06:24

UK Dividends Calendar - Week Ahead

Read more
12 Jan 2015 16:24

UK Dividends Calendar - Week Ahead

Read more
12 Jan 2015 06:18

UK Dividends Calendar - Week Ahead

Read more
9 Jan 2015 16:09

UK Dividends Calendar - Week Ahead

Read more
9 Jan 2015 06:20

UK Dividends Calendar - Week Ahead

Read more
4 Dec 2014 08:46

Thursday broker round-up

Aberdeen: Charles Stanley downgrades to 'hold'. Afren: Canaccord reduces target price from 115p to 65p, while staying with its 'speculative buy' recommendation. Amino Technologies: Northland moves target price from 120p to 130p and retains a 'buy' recommendation. Belgravium Technologies: WH Irelan

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.